BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6232201)

  • 1. Mechanisms of rejection and prolongation of vascularized organ allografts.
    Tilney NL; Kupiec-Weglinski JW; Heidecke CD; Lear PA; Strom TB
    Immunol Rev; 1984; 77():185-216. PubMed ID: 6232201
    [No Abstract]   [Full Text] [Related]  

  • 2. The inflammatory mechanisms of allograft rejection.
    Häyry P; von Willebrand E; Parthenais E; Nemlander A; Soots A; Lautenschlager I; Alfoldy P; Renkonen R
    Immunol Rev; 1984; 77():85-142. PubMed ID: 6232204
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ
    Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of prolongation of graft survival.
    Carpenter CB
    Transplant Proc; 1979 Dec; 11(4):1885-8. PubMed ID: 161100
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts.
    Padberg WM; Lord RH; Araneda D; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1053-6. PubMed ID: 2968695
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular basis of passive enhancement of graft survival.
    Pearce NW; Dorsch SE; Hall BM
    Transplant Proc; 1988 Feb; 20(1):53-5. PubMed ID: 2964113
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune mechanisms in organ allograft rejection.
    Lowry RP; Gurley KE; Forbes RD
    Transplant Proc; 1982 Dec; 14(4):679-81. PubMed ID: 6220495
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics and function of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplantation; 1989 Jun; 47(6):1001-7. PubMed ID: 2525288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indefinite acceptance of heart but not skin or islet allografts in rats by total lymphoid irradiation without intrathymic injection of donor cells.
    Papalois B; Wahoff D; Aasheim T; Griffin R; Nelson L; Field J; Sutherland DE
    Transplant Proc; 1995 Dec; 27(6):3190. PubMed ID: 8539905
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell.
    Hall BM
    J Exp Med; 1985 Jan; 161(1):123-33. PubMed ID: 3155790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of secondary suppressor response in enhanced allografted rats with endogenous suppressor activity in spleen and diminished cytotoxic T cell response.
    Weir MR; Salomon DR; Cohen DJ; Carpenter CB
    Transplantation; 1988 Nov; 46(5):731-9. PubMed ID: 2973670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector mechanisms in allograft rejection.
    Mason DW; Morris PJ
    Annu Rev Immunol; 1986; 4():119-45. PubMed ID: 3518743
    [No Abstract]   [Full Text] [Related]  

  • 13. Cells mediating allograft rejection.
    Hall BM; Dorsch SE
    Immunol Rev; 1984; 77():31-59. PubMed ID: 6232202
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
    Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
    J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1389-95. PubMed ID: 8516824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of cardiac allograft survival by suppressor T cells (Ts) generated in vitro using cyclosporine.
    Lenrow DA; Markmann JF; Shachner MS; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):473-4. PubMed ID: 2523144
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts.
    Padberg WM; Lord RH; Di Stefano R; Araneda D; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1988 Jan; 45(1):162-8. PubMed ID: 3276045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of cellular and humoral responses to skin and tumor allografts.
    Canty TG; Wunderlich JR
    Transplantation; 1971 Feb; 11(2):111-6. PubMed ID: 4931236
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
    Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL
    Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.